These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29528966)

  • 61. The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation.
    Geissler EK; Schlitt HJ
    Kidney Int; 2010 Dec; 78(11):1075-9. PubMed ID: 20861822
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Modern immunosuppression following renal transplantation. Standard or tailor made?].
    Budde K; Giessing M; Liefeldt L; Neumayer HH; Glander P
    Urologe A; 2006 Jan; 45(1):9-17. PubMed ID: 16328215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transplantation--a medical miracle of the 20th century.
    Morris PJ
    N Engl J Med; 2004 Dec; 351(26):2678-80. PubMed ID: 15616201
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunology insights into cardiac allograft rejection.
    Savasta M; Lentini S
    Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.
    Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B
    Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed.
    Webber AB; Vincenti F
    Transplantation; 2016 Apr; 100(4):836-43. PubMed ID: 27003097
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The spectrum of complications of immunosuppression: is the time right for hand transplantation?
    Brenner MJ; Tung TH; Jensen JN; Mackinnon SE
    J Bone Joint Surg Am; 2002 Oct; 84(10):1861-70. PubMed ID: 12377920
    [No Abstract]   [Full Text] [Related]  

  • 69. Some observations on prope tolerance.
    Calne R; Watson CJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacological manipulation of the rejection response.
    Hopkins PM
    Methods Mol Biol; 2006; 333():375-400. PubMed ID: 16790860
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Innovations in reconstructive microsurgery: Reconstructive transplantation.
    Kollar B; Tasigiorgos S; Dorante MI; Carty MJ; Talbot SG; Pomahac B
    J Surg Oncol; 2018 Oct; 118(5):800-806. PubMed ID: 30098294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Emerging Role of Nanotechnology in Cell and Organ Transplantation.
    Tasciotti E; Cabrera FJ; Evangelopoulos M; Martinez JO; Thekkedath UR; Kloc M; Ghobrial RM; Li XC; Grattoni A; Ferrari M
    Transplantation; 2016 Aug; 100(8):1629-38. PubMed ID: 27257995
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advances in immune-based therapies to improve solid organ graft survival.
    Rose SM; Turka L; Kerr L; Rotrosen D
    Adv Intern Med; 2001; 47():293-331. PubMed ID: 11795079
    [No Abstract]   [Full Text] [Related]  

  • 76. New goals to be achieved in clinical transplantation.
    Manez R
    Drug News Perspect; 2006 Oct; 19(8):509-12. PubMed ID: 17160153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Modern immunosuppression after solid organ transplantation].
    Beimler J; Morath C; Zeier M
    Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Xenotransplantation.
    Bigam D; Zhong R; Levy G; Grant D
    Can J Surg; 1999 Feb; 42(1):12-6. PubMed ID: 10071582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic allograft dysfunction: mechanisms and new approaches to therapy.
    Womer KL; Vella JP; Sayegh MH
    Semin Nephrol; 2000 Mar; 20(2):126-47. PubMed ID: 10746856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.
    Fisher JD; Acharya AP; Little SR
    Clin Immunol; 2015 Sep; 160(1):24-35. PubMed ID: 25937032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.